Leadership & Expert Views - Cancer Currents Blog
Commentaries from scientific leaders at NCI and other institutions about cancer research topics, programs, and initiatives.
-
NCI ALMANAC: A New Tool for Research on Cancer Drug CombinationsNCI has released a new, easy-to-use resource called the NCI ALMANAC to help researchers identify potentially promising combinations of cancer drugs.
-
Making Greater Progress Against Cancer—Not Just a Hope but a RealityActing NCI Director Dr. Doug Lowy discusses what he calls encouraging news in the most recent Annual Report to the Nation and how NCI is helping to achieve further progress against cancer.
-
Advancing the Potential and Promise of Total-Body PET ImagingA total-body PET scanner under development is an ideal example of how NCI and NIH are supporting the development of new research and cancer care-related technologies.
-
Colorectal Cancer Incidence Rising in Young Adults: An Interview with Drs. Philip Rosenberg and William AndersonDrs. Philip Rosenberg and William Anderson of NCI discuss a recent study on which they were coauthors that reported an increase in colorectal cancer incidence among adults under age 50 in the United States.
-
Putting the Cancer Patient Front and Center: An Interview with NCI’s Dr. Paul JacobsenNCI’s Dr. Paul Jacobsen discusses NCI’s Healthcare Delivery Research Program and its role in advancing innovative research to improve the delivery of cancer care.
-
Conditional Reprogramming: An Interview with Dr. Richard Schlegel on Growing Cancer CellsDr. Richard Schlegel describes an innovative cell culture technique he helped to develop. Called conditional reprogramming, the technique can be used to rapidly establish cell cultures of normal and tumor cells from patient samples.
-
Cancer Moonshot Moves Forward, Bringing Funding Opportunities for ResearchersNCI has issued a series of funding opportunity announcements aligned with goals of the recommendations in the Beau Biden Cancer Moonshot℠ Blue Ribbon Panel report released last fall.
-
NCTN/NCORP Data Archive: Expanding Access to Clinical Trial DataNCI is launching the NCTN/NCORP Data Archive, a centralized repository of patient-level data from phase III clinical trials conducted by NCI’s NCTN and NCORP trials programs and the National Cancer Institute of Canada-Clinical Trials Group.
-
The Global Economic Burden of Tobacco: An Interview with Dr. Mark ParascandolaNCI’s Dr. Mark Parascandola answers questions about The Economics of Tobacco and Tobacco Control, the latest in a series of monographs on tobacco use and tobacco control, which was co-written with the World Health Organization.
-
NCI’s Office of Cancer Survivorship: Celebrating 20 Years, Planning for Continued ProgressDr. Julia Rowland, director of NCI’s Office of Cancer Survivorship, on the office’s 20th anniversary and efforts to ensure continued progress in survivorship research and improve survivors’ lives.
-
Connected Health: An Important Tool for Making Progress against Cancer
A new report from the President’s Cancer Panel outlines how connective technologies can promote cancer prevention, enhance patients’ treatment experience, and accelerate progress in cancer research.
-
Educating Patients about Genetic Test Results: An Interview with Carol Weil about the COMET StudyThe recently launched COMET study will examine whether educating patients with cancer about genetic testing will increase their knowledge and reduce their stress levels after receiving genomic testing results.
-
Forging Collaborations to Spur Global Progress against CancerNCI and NIH announce efforts to establish international collaborations that can accelerate progress in reducing the global cancer burden.
-
Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer MoonshotNCI’s new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.
-
The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.Dr. Greg Armstrong of the Childhood Cancer Survivor Study discusses this long-running study and its future.
-
Blue Ribbon Panel Report: The Power of the Cancer Community Coming TogetherNCI Acting Director Dr. Douglas R. Lowy, M.D., thanks the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.
-
Setting the Stage for the Next Decade of Tobacco Control ResearchA new report from an NCI working group lays out recommended priorities to help shape the institute’s future tobacco control research portfolio.
-
The Cancer Moonshot Summit: Reaching New HeightsA recap of the Cancer Moonshot national summit hosted by Vice President Joe Biden in Washington, D.C., on June 29, 2016, including a summary of the NCI-related activities that have been stimulated by the Cancer Moonshot.
-
The Moonshot Blue Ribbon Panel: Moving Toward a Final ReportAn update on the activities of the National Cancer Moonshot Initiative’s Blue Ribbon Panel and its work to develop a final report for research ideas to be pursued under this initiative.
-
Charting a Course toward Precision Cancer PreventionCancer researchers are increasingly exploring how cancer risk is influenced by genetic predisposition to cancer and the effects of environmental exposures, and what this means for cancer prevention.